Published in Ciba Found Symp on January 01, 1986
Presynaptic regulation of catecholamine release. Biochem Pharmacol (1974) 6.69
Sixth gaddum memorial lecture, National Institute for Medical Research, Mill Hill, January 1977. Presynaptic receptors and their role in the regulation of transmitter release. Br J Pharmacol (1977) 6.01
International Union of Pharmacology. XV. Subtypes of gamma-aminobutyric acidA receptors: classification on the basis of subunit structure and receptor function. Pharmacol Rev (1998) 4.37
Presynaptic regulation of the release of catecholamines. Pharmacol Rev (1980) 4.20
Radioimmunometric assay for a monoclonal antibody-defined tumor marker, CA 19-9. Clin Chem (1983) 3.91
International Union of Pharmacology nomenclature of adrenoceptors. Pharmacol Rev (1994) 3.26
The metabolism of (3H)noradrenaline released by electrical stimulation from the isolated nictitating membrane of the cat and from the vas deferens of the rat. J Physiol (1970) 3.02
Preferential metabolism of (-) 3 H-norepinephrine through the deaminated glycol in the rat vas deferens. Biochem Pharmacol (1973) 2.87
International Union of Pharmacology. X. Recommendation for nomenclature of alpha 1-adrenoceptors: consensus update. Pharmacol Rev (1995) 2.53
The effect of a saturable uptake mechanism on the slopes of dose-response curves for sympathomimetic amines and on the shifts of dose-response curves produced by a competitive antagonist. J Pharmacol Exp Ther (1969) 2.48
Role of the -adrenoceptor in regulating noradrenaline overflow by nerve stimulation. Br J Pharmacol (1972) 2.09
Effects of phenoxybenzamine on the uptake and metabolism of noradrenaline in the rat heart and vas deferens. Br J Pharmacol (1969) 1.90
Possible role of a beta-adrenoceptor in the regulation of noradrenaline release by nerve stimulation through a positive feed-back mechanism. Br J Pharmacol (1975) 1.84
Physiological significance of alpha-adrenoceptor-mediated negative feedback mechanism regulating noradrenaline release during nerve stimulation. Nature (1977) 1.69
Influence of the frequency of nerve stimulation on the metabolism of 3H-norepinephrine released from the perfused cat spleen: differences observed during and after the period of stimulation. J Pharmacol Exp Ther (1976) 1.67
Release of norepinephrine and dopamine-beta-hydroxylase by nerve stimulation. I. Role of neuronal and extraneuronal uptake and of alpha presynaptic receptors. J Pharmacol Exp Ther (1974) 1.56
Immunodiagnosis of hepatitis B with high-affinity IgM monoclonal antibodies. Proc Natl Acad Sci U S A (1981) 1.48
Time course of the development of supersensitivity to various amines in the nictitating membrane of the pithed cat after denervation or decentralization. J Pharmacol Exp Ther (1967) 1.48
Effects of dopamine and alpha-methyl-dopamine on smooth muscle and on the cardiac pacemaker. J Pharmacol Exp Ther (1967) 1.40
Total and direct-reacting bilirubin values by automated methods compared with liquid chromatography and with manual methods for determining delta bilirubin. Clin Chem (1990) 1.39
Heterogeneity of smooth muscle alpha adrenoceptors in rat tail artery in vitro. J Pharmacol Exp Ther (1984) 1.39
Histochemical and fine structural aspects of the onset of denervation supersensitivity in the nictitating membrane of the spinal cat. J Pharmacol Exp Ther (1967) 1.34
Noradrenaline release from isolated muscles of the nictitating membrane of the cat. J Physiol (1971) 1.27
Influence of reserpine-induced depletion of noradrenaline on the negative feed-back mechanism for transmitter release during nerve stimulation. Br J Pharmacol (1973) 1.24
Specific high-affinity saturable binding of [3H] R05-4864 to benzodiazepine binding sites in the rat cerebral cortex. Eur J Pharmacol (1981) 1.19
Zolpidem, a novel nonbenzodiazepine hypnotic. I. Neuropharmacological and behavioral effects. J Pharmacol Exp Ther (1986) 1.19
Alpha-adrenoreceptor subtypes in blood vessels: physiology and pharmacology. J Cardiovasc Pharmacol (1984) 1.18
Possible involvement of a transmitter different from norepinephrine in the residual responses to nerve stimulation of the cat nictitating membrane after pretreatment with reserpine. J Pharmacol Exp Ther (1976) 1.17
Differential effects of alpha-beta-methylene ATP on responses to nerve stimulation in SHR and WKY tail arteries. Naunyn Schmiedebergs Arch Pharmacol (1986) 1.15
Metabolism of norepinephrine released by phenoxybenzamine in isolated guinea-pig atria. J Pharmacol Exp Ther (1972) 1.15
Diltiazem enhancement of [3H]nitrendipine binding to calcium channel associated drug receptor sites in rat brain synaptosomes. Biochem Biophys Res Commun (1982) 1.11
High-affinity [3H]imipramine binding in rat hypothalamus: association with uptake of serotonin but not of norepinephrine. Science (1980) 1.10
Specific tricyclic antidepressant binding sites in rat brain. Nature (1979) 1.09
Improved processing technique for renal biopsies for light microscopy. J Clin Pathol (1970) 1.08
Dopamine transporter density is decreased in parkinsonian patients with a history of manganese exposure: what does it mean? Mov Disord (2002) 1.06
Presence of postsynaptic alpha 2-adrenoreceptors of predominantly extrasynaptic location in the vascular smooth muscle of the dog hind limb. Clin Sci (Lond) (1980) 1.05
Expression of alpha 1-adrenoceptor subtypes in rat tissues: implications for alpha 1-adrenoceptor classification. Eur J Pharmacol (1994) 1.05
Specific high-affinity binding sites for [3H]Ro 5-4864 in rat brain and kidney. J Pharmacol Exp Ther (1983) 1.05
Tritiated imipramine binding sites are decreased in platelets of untreated depressed patients. Science (1980) 1.05
Mechanisms involved in the antiplatelet activity of Staphylococcus aureus lipoteichoic acid in human platelets. Thromb Haemost (2000) 1.04
Pharmacological profile of the imidazopyridine zolpidem at benzodiazepine receptors and electrocorticogram in rats. Naunyn Schmiedebergs Arch Pharmacol (1985) 1.04
Morphine and beta-endorphin inhibit release of noradrenaline from cerebral cortex but not of dopamine from rat striatum. Nature (1978) 1.03
Effects of flow-stop on the metabolism of noradrenaline released by nerve stimulation in the perfused spleen. Naunyn Schmiedebergs Arch Pharmacol (1973) 1.03
Filgrastim. A review of its pharmacological properties and therapeutic efficacy in neutropenia. Drugs (1994) 1.03
Selective metabolic pathways for noradrena-line in the peripheral and in the central nervous system. Med Biol (1974) 1.03
The effects of phenoxybenzamine on metabolism of 3H-noradrenaline released from the isolated nictitating membrane. Br J Pharmacol (1968) 1.02
The relation of retention of norepineephrine-H3 to the norepinephrine content of the nictitating membrane of the spinal cat during development of denervation supersensitivity. J Pharmacol Exp Ther (1966) 1.01
The striatal cholinergic interneuron: synaptic target of dopaminergic terminals? Neuroscience (1983) 1.01
The effect of lithium salts on the urinary excretion of -oxoglutarate in man. Br J Pharmacol (1972) 1.00
Monoamine oxidase and catechol-O-methyl transferase activities in cat nictitating membrane and rat and guinea-pig vas deferens after sympathectomy. Br J Pharmacol (1968) 0.99
The potentiation of responses to adrenergic nerve stimulation in the presence of cocaine: its relationship to the metabolic fate of released norepinephrine. J Pharmacol Exp Ther (1974) 0.98
New evidence that the pharmacological effects of benzodiazepine receptor ligands can be associated with activities at different BZ (omega) receptor subtypes. Psychopharmacology (Berl) (1999) 0.97
SL651498: an anxioselective compound with functional selectivity for alpha2- and alpha3-containing gamma-aminobutyric acid(A) (GABA(A)) receptors. J Pharmacol Exp Ther (2001) 0.97
In vivo and in vitro interaction of the novel selective histamine H1 receptor antagonist mizolastine with H1 receptors in the rodent. Arzneimittelforschung (1995) 0.95
The onset of denervation supersensitivity. J Pharmacol Exp Ther (1966) 0.95
Inhibition of neuronal uptake reduces the presynaptic effects of clonidine but not of alpha-methylnoradrenaline on the stimulation-evoked release of 3H-noradrenaline from rat occipital cortex slices. Eur J Pharmacol (1980) 0.95
Differences between presynaptic and postsynaptic alpha-adrenoceptors in the isolated nictitating membrane of the cat: effects of metanephrine and tolazoline. Br J Pharmacol (1978) 0.95
Inhibition by dopamine of 3H-noradrenaline release elicited by nerve stimulation in the isolated cat's nictitating membrane. Naunyn Schmiedebergs Arch Pharmacol (1975) 0.94
Haloperidol-induced catalepsy is absent in dopamine D(2), but maintained in dopamine D(3) receptor knock-out mice. Eur J Pharmacol (2000) 0.94
gamma-Aminobutyric acid (GABA) receptor stimulation. II. Specificity of progabide (SL 76002) and SL 75102 for the GABA receptor. J Pharmacol Exp Ther (1982) 0.93
Use of the clonal assay for the measurement of frequencies of HPRT mutants in T-lymphocytes from five control populations. Mutat Res (1991) 0.93
Evaluation of exposure to ethylene glycol monoethyl ether acetates and their possible haematological effects on shipyard painters. Occup Environ Med (1999) 0.93
Cocaine and amphetamine antagonize the decrease of noradrenergic neurotransmission elicited by oxymetazoline but potentiate the inhibition by alpha-methylnorepinephrine in the perfused cat spleen. J Pharmacol Exp Ther (1981) 0.93
Sodium dependent [3H]cocaine binding associated with dopamine uptake sites in the rat striatum and human putamen decrease after dopaminergic denervation and in Parkinsons disease. Naunyn Schmiedebergs Arch Pharmacol (1985) 0.93
Muscarinic receptors on dopamine terminals in the cat caudate nucleus: neuromodulation of [3H]dopamine release in vitro by endogenous acetylcholine. Brain Res (1982) 0.92
Evidence against a physiological role of prostaglandins in the regulation of noradrenaline release in the cat spleen. J Physiol (1975) 0.92
The relationship of plasma to erythrocyte lithium levels in patients taking lithium carbonate. Br J Psychiatry (1975) 0.92
Modulation of the gamma-aminobutyric acid type A receptor by the antiepileptic drugs carbamazepine and phenytoin. Mol Pharmacol (1995) 0.92
Influence of GABA receptor agonists and antagonists on the binding of 3H-diazepam to the benzodiazepine receptor. Eur J Pharmacol (1978) 0.92
Intrinsic and integrative properties of substantia nigra pars reticulata neurons. Neuroscience (2011) 0.92
Specific tricyclic antidepressant binding sites in rat brain characterised by high-affinity 3H-imipramine binding. Eur J Pharmacol (1980) 0.91
Possible physiological significance of the initial step in the catabolism of noradrenaline in the central nervous system of the rat. Naunyn Schmiedebergs Arch Pharmacol (1977) 0.91
A common binding site for tricyclic and nontricyclic 5-hydroxytryptamine uptake inhibitors at the substrate recognition site of the neuronal sodium-dependent 5-hydroxytryptamine transporter. Biochem Pharmacol (1989) 0.91
Effects of cocaine or denervation on responses of isolated strips of cat spleen to (-)-noradrenaline and (-)-isoprenaline. Br J Pharmacol (1973) 0.91
Effects of antidepressants on monoamine transporters. Prog Neuropsychopharmacol Biol Psychiatry (1988) 0.90
High-affinity [3H]desipramine binding in the peripheral and central nervous system: a specific site associated with the neuronal uptake of noradrenaline. Eur J Pharmacol (1982) 0.90
The effects of the 2-amino-tetrahydronaphthalene derivative M7, a selective alpha 2-adrenoceptor agonist in vitro. Naunyn Schmiedebergs Arch Pharmacol (1981) 0.90
Comparative analysis of beta-1 adrenoceptor agonist and antagonist potency and selectivity of cicloprolol, xamoterol and pindolol. J Pharmacol Exp Ther (1987) 0.90
Covalent enzyme-RNA complex: a tRNA modification that prevents a covalent enzyme interaction also prevents aminoacylation. Proc Natl Acad Sci U S A (1985) 0.90
[3H]diltiazem binding to calcium channel antagonists recognition sites in rat cerebral cortex. Eur J Pharmacol (1985) 0.90
The neuroprotective properties of ifenprodil, a novel NMDA receptor antagonist, in neuronal cell culture toxicity studies. Eur J Pharmacol (1992) 0.90
Changes in monoamine oxidase and catechol-0-methyl transferase activities after denervation of the nictitating membrane of the cat. J Physiol (1971) 0.90
Subsensitivity of presynaptic alpha-adrenoceptors after exposure to noradrenaline. Eur J Pharmacol (1977) 0.90
Postjunctional alpha 1-adrenoceptors: preferential innervation of alpha 1-adrenoceptors and the role of neuronal uptake. J Cardiovasc Pharmacol (1982) 0.89
Inhibitory effects of alpha, beta-methylene ATP on nerve-mediated contractions of the nictitating membrane in reserpinised cats. Eur J Pharmacol (1985) 0.89
The degeneration contraction of the nictitating membrane in the unanesthetized cat. J Pharmacol Exp Ther (1966) 0.89
Identification of alpha 1-adrenoceptor subtypes present in the human prostate. Life Sci (1994) 0.89
Benzodiazepine receptor binding in young, mature and senescent rat brain and kidney. Neurobiol Aging (1981) 0.89
Possible role of cyclic nucleotides in regulation of noradrenaline release from rat pineal through presynaptic adrenoceptors. Nature (1978) 0.89
High-affinity binding of 3H-imipramine in brain and platelets and its relevance to the biochemistry of affective disorders. Life Sci (1981) 0.89
Release of radioactive purines from cat nictitating membrane labeled with 3H-adenine. Eur J Pharmacol (1979) 0.89
Synthesis and SAR of 3- and 4-substituted quinolin-2-ones: discovery of mixed 5-HT(1B)/5-HT(2A) receptor antagonists. Bioorg Med Chem (2001) 0.89
Pre- and postsynaptic origin of the norepinephrine metabolites formed during transmitter release elicited by nerve stimulation. J Pharmacol Exp Ther (1972) 0.89
Amisulpride: from animal pharmacology to therapeutic action. Int Clin Psychopharmacol (1997) 0.89
Litoxetine: a selective 5-HT uptake inhibitor with concomitant 5-HT3 receptor antagonist and antiemetic properties. Eur J Pharmacol (1993) 0.89